![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 43, 30943-30949, October 22, 1999
andFrom the Institute of Molecular Biology, University of Vienna, Vienna BioCenter, Dr. Bohr-Gasse 9, A-1030 Vienna, Austria
| |
ABSTRACT |
|---|
|
|
|---|
Thymidine kinase (TK) genes from different
species are growth- and cell cycle-regulated in a very similar manner;
still, the promoter regions of these genes show little homology to each
other. It was previously shown that the murine TK gene is
growth-regulated by Sp1 and E2F. Here we have characterized
cis-regulatory elements in the hamster promoter that are
essential and sufficient to confer efficient and serum-responsive
expression. The TK promoter was isolated from baby hamster kidney
cells. DNase I protection experiments revealed a protected region from
positions Thymidine kinase (TK)1
is a salvage pathway enzyme that functions in the phosphorylation of
thymidine to form TMP at the expense of ATP and thereby contributes to
the pool of thymidine nucleotides for DNA replication. Mammalian cells
carry two TK genes, one coding for the mitochondrial enzyme and the
other one for the cytoplasmic enzyme, which is the subject of this
report. The expression of cytoplasmic TK is strongly growth- and cell
cycle-regulated at the transcriptional as well as at several
post-transcriptional levels (reviewed in Refs. 1 and 2). TK mRNA is
hardly detectable in growth-arrested cells, whereas its synthesis is
dramatically stimulated at the border of G1 to S phase of
the cell cycle. Many genes coding for enzymes involved in DNA
replication and precursor production are regulated similarly. Not
surprisingly, the promoters of such genes exhibit high degrees of
sequence homology between organisms. For instance, the promoter of
another gene involved in precursor production, that of dihydrofolate
reductase, is very similar between human and various different rodents
(reviewed in Ref. 3). This is not true for the TK genes, where
different species show remarkably divergent sequences in the promoter
region, whereas the expressed part of the genes is highly homologous. This might indicate variation in the mechanisms of transcriptional regulation of these genes. The TATA-less murine TK promoter (4), for
example, contains one Sp1-binding site and a binding motif for the
growth-regulated transcription factor family E2F within the region
important for growth-regulated expression (5, 6), the latter closely
resembling a similar motif present in the promoter of the dihydrofolate
reductase gene. Both the Sp1 and E2F sites are necessary for regulated
expression of the murine TK gene (5-7), and Sp1 and E2F-1-3 have in
fact been shown to directly interact (8). The human TK promoter, on the
other hand, carries Sp1 sites, several motifs resembling E2F-binding
sites, two reversed CCAAT boxes, and a TATA element (9). The upstream
region of the TK gene from Chinese hamster cells was reported
previously (10-12); however, transcription factor-binding sites and
the proteins involved in the regulation of the gene have not been
identified. We were intrigued by the differences in the structures of
the TK promoters, which contrast with the high homology displayed by
the expressed part of the genes, and report here on our detailed analysis of the hamster TK promoter derived from BHK cells. We present
evidence that this TATA-containing promoter is regulated by Sp1 and the
CCAAT-binding transcription factor NF-Y, whereas the E2F-like sequence
is dispensable and does not bind transcription factors of the E2F
family. The transcription factor pair Sp1/NF-Y is active on the hamster
promoter and appears to functionally replace the transcription factor
pair Sp1/E2F, which is active on the murine TK promoter. Thus, although
the murine and hamster TK genes are regulated very similarly during
growth, the mechanism of this regulation is clearly distinct.
Furthermore, from the results presented in this report, it appears
questionable to generally regard TK as an E2F-regulated gene.
Isolation of the Hamster TK Promoter from BHK Cells and Plasmid
Constructions--
Genomic DNA was prepared from BHK cells using
standard procedures (13). The TK promoter was amplified by polymerase
chain reaction using primer sequences derived from the upstream region (5'-CAAGCGGTACCTGCCCTGAAG-3') and from exon 1 (5'-GTAATTGCTAGCGGCTGTGCG-3') of the Chinese hamster TK gene (11). The
polymerase chain reaction products contained engineered restriction
sites for KpnI and NheI, which were used for
subcloning into pGEM3Zf(
Mutations within the promoter region were produced using the Bio-Rad
system for oligonucleotide-directed in vitro mutagenesis. The mutations were chosen to produce a unique restriction site at the
selected position and are schematically presented in Fig. 5C. All mutations were verified by sequencing. Wild-type and
mutated TK promoter fragments were cloned into the KpnI and
NheI sites of the plasmid pGL2neo. This plasmid was
constructed by introducing the neo gene under the control of
the SV40 early promoter into the BamHI site of plasmid
pGL2-Basic (Promega).
For the construction of truncated promoter fragments, the unique
restriction sites in the mutated transcription factor-binding sites
were used. The fragments were cut at these sites; blunt-ended; and then
digested with NheI, followed by cloning into correspondingly digested pGL2neo.
Cell Culture, Transfection, and Selection of a Stable Cell
Line--
BHK cells were grown in Dulbecco's modified Eagle's medium
containing 10% fetal calf serum, penicillin, and streptomycin. To
generate stably transfected cells, 5 µg of the plasmid of interest were linearized with XmnI and transfected into BHK cells
using Polybrene-assisted gene transfer (14). Stably transfected cells were selected in the presence of Geneticin (600 µg/ml; Life
Technologies, Inc.). Clones were pooled after 12-14 days and expanded
in medium containing Geneticin (300 µg/ml). The drug was removed only
shortly prior to the experimental assays.
Harvesting of cells and preparation of cell extracts for luciferase
assays were performed as described elsewhere (15). Growth arrest of
cells in G0 was accomplished by reducing the concentration of serum to 0.5% for 72 h. Restimulation was achieved by the
addition of serum to 20%.
For flow cytometry, cells were trypsinized, washed with
phosphate-buffered saline, and fixed in 85% ethanol. The fixed cells were suspended in a few drops of 0.05% pepsin, stained with
4,6-diamidino-2-phenylindole (Merck) and sulforhodamine 101 (Sigma),
and analyzed in a Partec PAS-2 cytofluorometer.
Transient Transfections--
For transient transfections, the
wild-type hamster TK promoter or a SmaI-NheI
fragment (564 base pairs) of the 5'-upstream sequence of the mouse TK
gene (8) was cloned into the KpnI and NheI sites
of the plasmid pGL3-Basic (Promega). The E2F-1 expression vector,
pRcCMV-HA-E2F-1(wt), was a gift of Dr. Wilhelm Krek; the DP-1
expression vector, pCMV-HA-DP-1, was kindly provided by Dr. Kristian Helin.
SAOS-2 cells (9 × 104) or BHK cells (6.5 × 104) were seeded in 3-cm diameter Petri dishes and
transfected the following day with a total of 1.8 or 1.2 µg of DNA,
respectively, using polyethyleneimine-assisted gene transfer (15). 6 µl of polyethyleneimine (10 mM polyethyleneimine, Mr 25,000) were diluted with 250 µl of 20 mM HEPES (pH 7.4) and added dropwise to 6 µg of DNA
diluted in 250 µl of 20 mM HEPES (pH 7.4), with gentle
agitation after the addition of each drop. After a 20-min incubation at
room temperature, the appropriate amounts of DNA-polyethyleneimine
complexes were added to the cells, which, prior to the transfection,
had their growth medium replaced by 800 µl of serum-free medium. The
transfection medium was replaced by fresh medium after 4 h. After
48 h, luciferase/ Preparation of Nuclear Extracts--
Crude nuclear extracts were
prepared from exponentially growing BHK cells as described previously
(16). Briefly, cells were washed twice with phosphate-buffered saline,
collected in a conical tube, and centrifuged for 10 min at 1000 rpm.
The cell pellet was washed once with ice-cold phosphate-buffered saline
and resuspended in 3 volumes of hypotonic buffer (10 mM
HEPES (pH 7.9), 10 mM KCl, 1.5 mM
MgCl2, 0.3 mM phenylmethylsulfonyl fluoride,
and 0.5 mM dithiothreitol). After 20 min on ice, the cells
were homogenized using a syringe with a 27-gauge needle, and the nuclei
were pelleted by centrifugation for 8 min at 5000 rpm. Nuclei were
resuspended in 1 volume of lysis buffer (20 mM HEPES (pH
7.9), 0.42 M NaCl, 1.5 mM MgCl2,
0.2 mM EDTA, 25% glycerol, 0.3 mM
phenylmethylsulfonyl fluoride, and 0.5 mM dithiothreitol),
and the lysate was incubated at 4 °C for 30 min with gentle mixing.
The nuclear extract was obtained by centrifugation at 14,000 rpm for 30 min.
Preparation of Whole Cell Extracts--
For the preparation of
whole cell extracts, cells were washed twice with cold
phosphate-buffered saline, collected in an Eppendorf tube, and
centrifuged for 5 s. The cell pellet was suspended in 3 volumes of
extraction buffer (20 mM HEPES (pH 7.9), 0.4 M
NaCl, 25% glycerol, 1 mM EDTA, and 0.2 mM
phenylmethylsulfonyl fluoride). Cells were lysed by one freeze/thaw
cycle in liquid nitrogen and at 37 °C, respectively. After 20 min on
ice, the extracts were obtained by centrifugation for 10 min at 14,000 rpm.
Electrophoretic Mobility Shift Assays--
Binding reactions
were carried out in a volume of 20 µl by incubating 10 µg of
protein extract and 1 µg of salmon sperm DNA in a buffer containing
20 mM HEPES (pH 7.9), 40 mM KCl, 1 mM MgCl2, 4% Ficoll, 0.1 mM EDTA,
0.1% Nonidet P-40, and 1 mM dithiothreitol. After 10 min
on ice, end-labeled oligonucleotides were added, and the incubation was
continued at room temperature for 20 min. This was followed by
electrophoresis on a 4% polyacrylamide gel and autoradiography of the
dried gel. For competition experiments, a 100-fold excess of unlabeled
competitor DNA was incubated with the protein extract for 10 min before
the labeled oligonucleotide was added. The sequences of the top strands
of the individual oligonucleotide probes were as follows: E2F-like
motif, 5'-CTCCTGGCTTTGCAGGGACACGAGGAGGC-3'; GC box 1, 5'-CACGAGGAGGCAGGGGGCGGGGCCCACACG-3'; GC box 2, 5'-CACACGCGCCCCGCCCTCGCCACG-3'; GC box 3, 5'-CCCTCGCCACGCCCCTGTCTGCGGCT-3'; and CCAAT box,
5'-GATCCGGCTGCGATTGGTCGGT-3'.
DNase I Protection Assay--
The assays were performed as
described (17) with the following modifications. The coding strand of
the TK promoter fragment between positions Isolation of the Hamster TK Promoter--
The TK gene, the
cDNA sequence, and the 5'-upstream region were previously
identified from Chinese hamster cells (10-12). However, a functional
analysis of the promoter sequence has not been carried out. The
presumptive promoter sequence differs significantly from that of other
rodents as well as from the human TK gene. In fact, there is little
homology among six TK promoters, five mammalian and the chicken
promoter (reviewed in Ref. 2). This contrasts with the high homology of
sequences within both the transcribed regions of the genes and the more
distant upstream regions. We used these homologous sequences to design
oligonucleotides for polymerase chain reaction to isolate the TK
promoter from BHK cells (derived from the Syrian hamster). As shown in
Fig. 1, the promoter carries several GC
motifs (potential binding sites for the transcription factor Sp1), one
reversed CCAAT box, and a TATA element. In this respect, the sequence
reported here is similar to the previously described 5'-upstream
sequence of the Chinese hamster gene (11). Furthermore, a sequence with
some resemblance to a binding site for E2F is discernible. This is of
particular interest since E2F was shown to play an important role in
the regulation of the murine TK promoter (5-8) and may also be
involved in the control of human TK (18, 19). We used the TK promoter from BHK cells to clarify which transcription factors are involved in
the growth-dependent regulation of the hamster TK gene.
In Vitro Footprint Analysis Reveals a Protected Region from
Positions Sp1 Binds to the GC Boxes, and NF-Y Binds to the Reversed CCAAT
Box--
We next wished to define the transcription factors binding
within the upstream protected region. The region between positions
Interestingly, no protein complexes were detected with the E2F-like
sequence within the hamster TK promoter, in contrast to what was found
with the functional E2F-binding site from the murine TK promoter (Fig.
3E). More important, the binding activity for the hamster
E2F-like sequence was absent in whole cell extracts from both quiescent
and serum-stimulated BHK cells.
A Minimal Promoter of 122 Base Pairs Is Sufficient for
Growth-regulated Expression--
To examine which of the transcription
factor-binding sites are essential for promoter activity and
growth-dependent regulation, two approaches were taken.
Luciferase reporter constructs were created, first with shortened
versions of the promoter and second with individual transcription
factor-binding sites mutated so as to eliminate their capacity to bind
the factor. The promoter-luciferase constructs were stably transfected
into BHK cells, and a pool of selected cells, rather than individual
clones, was used to avoid effects due to site of integration and copy number.
Results from the first approach, the deletion analysis of the promoter,
are summarized in Fig. 5. Stable cell
lines of BHK cells were synchronized in G0 by serum
starvation for 72 h, and the promoter activity was analyzed after
serum stimulation. Deletion of much of the upstream region, including
the E2F-like sequence (pTK( Functional Requirement of cis-Acting Elements for TK Promoter
Strength and Growth-regulated Expression--
Having shown that GC box
3, the CCAAT motif, and the TATA box are sufficient for regulated
expression of the promoter-luciferase constructs, these motifs were
individually mutated, as indicated in Fig.
6C, to examine their
involvement in promoter activity. Furthermore, because of the
importance of a potential role of the upstream E2F-like sequence, we
also mutated this sequence. Evidence that the mutations of the GC box
and the CCAAT motif abolished protein binding is demonstrated by the
DNase I protection assay (Fig. 2A). For all the mutations
analyzed, this was also confirmed by mobility shift experiments (data
not shown). The respective promoter-luciferase constructs were stably
integrated into BHK cells, and the activity and regulation were
analyzed using a pool of selected clones. In agreement with the results obtained with promoter constructs in which the E2F-like motif was
deleted (Fig. 5), point mutations in this motif had little effect on
promoter activity and growth-dependent regulation (Fig. 6,
A and B). Together with the observation that no
protein complexes were observed in electrophoretic mobility shift
experiments with the E2F-like sequence (Fig. 3E), we can
exclude that this upstream E2F-like element has a functional role in
the expression of the hamster TK gene. In contrast, a dramatic
reduction in hamster TK promoter activity was observed when either the
TATA or CCAAT box was mutated (Fig. 6, A and B).
Mutation of GC box 3 also led to a significant reduction in promoter
activity (~16% of that of the wild type); however, this residual
activity was still growth-dependent (Fig. 6B).
This contrasts with the results obtained with the promoter construct
carrying a mutated CCAAT box. This not only exhibited strongly reduced
activity, but this activity increased maximally 2-fold upon serum
stimulation. The transgene under the promoter with the mutated TATA
element displayed background activity indistinguishable from that
measured with an empty plasmid lacking any promoter. As expected for a
promoter containing a TATA element, this is absolutely essential for
promoter activity. Under these conditions, it is impossible to exclude
any role of this element in growth regulation. However, if we mutated
the TATA box within the context of the regulated minimal promoter such
that it resembled the TATA element active in the growth-independent
promoter of the muscle actin gene, this had no effect on promoter
regulation (data not shown). Taken together, the results summarized in
Figs. 5 and 6 show that GC box 3, the CCAAT box, and the TATA element
are essential and sufficient to confer efficient promoter activity. They furthermore indicate that binding of NF-Y to the reverse CCAAT box
is not only required for transcriptional activation, but also plays an
important role in growth-dependent regulation of the
hamster TK gene.
In Contrast to the Murine TK Promoter, the Hamster TK Promoter Is
Not Transactivated by E2F-1--
Since it has been shown that members
of the E2F transcription factor family, which heterodimerize with DP-1
and DP-2, are involved in the regulation of numerous genes that are
expressed at the G1 to S phase transition (21), we
investigated the possibility that E2F transactivates the hamster TK
promoter through an as yet unidentified element. To test this
possibility, reporter constructs containing the wild-type Initiation of DNA replication requires the expression of a large
number of genes at the G1/S boundary of the cell cycle.
Prominent among these are the enzymes involved in DNA replication and
precursor production as well as G1 and S phase-specific
cyclins, especially cyclins E and A. In many cases, a family of
transcription factors, called E2F, is found to be involved in this
regulation. E2F binds as a heterodimer with another group of proteins,
called DP, to a DNA-binding motif present in the promoters of many of
the genes expressed at the transition from G1 to S phase
and is regulated by the retinoblastoma protein pRb or its relatives
p107 and p130 (21). One of the more intensively studied examples of a
gene regulated during the cell cycle is the TK gene. Previous studies of the 5'-upstream region of the murine TK gene have supported a
central role of the E2F family members in this regulation (5-8). Although the human TK promoter contains an element that resembles an
E2F-binding site, the transcription factor binding to this site was
reported to be distinct from the known E2F proteins (22). In fact, a
clear involvement of E2F has so far only been proven for the regulation
of the murine TK gene. Furthermore, a comparison of the promoter
sequences of six vertebrates revealed astonishing differences (2),
suggesting that each promoter is regulated by a distinct mechanism.
In this report, we describe the first detailed functional analysis of
the hamster TK promoter. The promoter region was isolated from BHK
cells. Analysis of the sequence revealed similarities to the human TK
promoter in that both contain a TATA box and a CCAAT box, several GC
motifs, and an element resembling an E2F-binding site. This structure
is different from that of the murine TK promoter, which lacks both a
TATA box and CCAAT motifs. However, in contrast to what has been shown
for the human promoter (18, 19), the deletion and mutational analyses
presented here clearly show that the E2F-like binding element does not
play any functional role in the activation or regulation of the hamster
TK promoter (Figs. 5 and 6). More important, overexpression of E2F-1
could not transactivate the hamster promoter, as could be demonstrated
with the murine TK promoter (Fig. 7). Taken together, these results
strongly suggest that the hamster TK promoter is regulated by a
mechanism distinct from both the human and murine ones and independent
of E2F.
We identified a 122-base pair fragment between positions NF-Y, also named CBF or CP1, is composed of three subunits, A, B, and
C, all of which are required for DNA binding (reviewed in Ref. 23). The
sequence of the subunits is highly conserved (with >90% identity)
among different mammalian species. NF-Y was initially identified as a
transcription factor that interacts with the CCAAT motif of the major
histocompatibility complex class II promoter (24). Interestingly, NF-Y
was found to recognize CCAAT boxes in several growth-regulated genes,
including murine ribonucleotide reductase R2 (25), murine E2F-1 (26),
cyclin B1 (27), cdc2, cyclin A, the protein phosphatase
cdc25C (28), and human TK (29-31). The S- and
G2-specific cyclin A, cdc2, and cdc25C genes also contain a downstream CDE/CHR element that
consists of a very conserved sequence, (G/C)GCGGN5TTGAA,
which has been shown to be occupied only in G0 and
G1 and to act as a transcriptional repressor of the
transactivating activity of upstream binding sites, including the NF-Y
recognition site (28). Since this element is absent in the promoter
sequence described here, it is highly unlikely that this is the
mechanism through which the hamster TK promoter is regulated.
The human TK promoter carries two CCAAT elements, to which NF-Y binds
and which were shown to be important for both activation and regulation
of the promoter (29-31). One report has suggested that the CCAAT
displacement protein CDP/cut plays a role in this regulation (31).
CDP/cut binds to sequences encompassing two CCAAT elements and acts as
a repressor by preventing the interaction of the CCAAT-binding factor
(17). It was shown that CDP/cut binds through the two CCAAT boxes in
the human promoter when overexpressed in quiescent cells, thereby
replacing bound NF-Y and exerting negative regulation (31).
Interestingly, in vivo footprinting experiments on the human
TK promoter showed that the E2F site, the GC boxes, and both CCAAT
motifs are protected throughout the cell cycle (32), indicating that
proteins are bound to these sites at all times, a situation reminiscent
of that at the mouse TK promoter (8). The fact that the hamster TK
promoter contains only one CCAAT box renders it unlikely that CDP/cut
plays a role in this case. Moreover, we were not able to detect binding
of CDP/cut to the promoter sequence reported here in mobility shift assays (data not shown). This adds additional support to the idea that
the hamster and human TK promoters are regulated differently.
The hamster TK promoter seems to be regulated by a single Sp1-binding
site and one CCAAT box, which leads one to speculate that, in this
promoter, NF-Y replaces the function of E2F, which has been
demonstrated to cooperatively regulate the murine TK promoter with Sp1.
Cooperative binding of NF-Y and Sp1 has in fact been described in the
regulation of other promoters (33, 34). Although Sp1 was not required
for growth-dependent regulation of the hamster TK promoter
(Fig. 6B), this element plays an important role in promoter
strength (Fig. 6A). It is therefore possible that Sp1
cooperates with NF-Y to enhance the growth-regulated expression of the
hamster promoter. Since NF-Y also recognizes CCAAT elements present in
non-cell cycle-regulated promoters, growth- and cell cycle-specific
regulation through NF-Y must certainly be dependent upon its promoter
context. Therefore, the proximity of the NF-Y-binding site in the
hamster TK promoter to the Sp1 and TATA elements might be very
important in this particular setting. There is evidence for an
important role of NF-Y in establishing transcription complexes and for
recruitment of upstream DNA-binding factors (35, 36). In light of the
observations that E2F (37), pRb (38-40), and Sp1 (43) interact with
histone-modifying enzymes, it is interesting that NF-Y was shown to
associate with the histone acetyltransferases P/CAF (41) and p300/CBP
(42). It is therefore possible that the common strategy for regulating
the murine and hamster and possibly other TK promoters involves
growth-dependent changes in chromatin structure through
local histone modification.
24 to
99 relative to the transcription start site. Within
this region, binding sites for the transcription factor Sp1 and a CCAAT
box, which interacts with the transcription factor NF-Y, were
identified. An E2F-like sequence was found not to bind protein, and its
removal did not affect promoter activity. This was supported by the
observation that cotransfection of a hamster TK reporter gene construct
with E2F-1 does not lead to transactivation of the promoter. A 122-base pair region that contains a single Sp1 site, a CCAAT box, and a TATA
element was found to be sufficient for serum-responsive expression of a
reporter gene. Mutations that inactivate any one of these three
elements caused a strong reduction or a loss of promoter activity.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
). Four different clones were sequenced to
avoid polymerase chain reaction-generated mutations.
-galactosidase assays were performed using the
Dual-Light system (Tropix Inc.) as recommended by the vendor.
319 and +51 was
end-labeled by filling in the NheI site at position +51.
Binding reactions were carried out by incubating 30 µg of nuclear
protein in a final volume of 50 µl of buffer containing 20 mM HEPES (pH 7.9), 60 mM KCl, 8% glycerol, 0.8 mM MgCl2, 1 mM dithiothreitol, and
1 µg of poly(dI-dC). After 10 min on ice, the end-labeled DNA
fragment was added, and the reactions were incubated for 20 min at room
temperature before 3 units of DNase I were added, and digestion was
allowed for 60 s. The DNase was inactivated by the addition of 0.6 M NaCl, 0.2% SDS, and 10 mM EDTA, followed by
phenol extraction and ethanol precipitation. The DNA was then analyzed
on denaturing 6% polyacrylamide gels.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (28K):
[in a new window]
Fig. 1.
5'-Upstream region of the TK gene isolated
from BHK cells. Putative control elements are
underlined. The transcription initiation site is indicated
by an arrow.
99 to
24--
To identify protein-binding sites within
the hamster TK promoter, we carried out DNase I protection assays. A
clear protection of the three GC boxes and of the reversed CCAAT box
was observed when the coding strand of the promoter fragment from
positions
319 to +51 (relative to the transcription start site) was
incubated with nuclear extract from exponentially growing BHK cells
(Fig. 2A). To further map the
region of protection contributed by individual transcription factors,
single mutations were introduced in the binding motifs. The results
shown in Fig. 2A indicate the binding of four protein
complexes, which correspond to the number of putative binding sites,
and that protein binding was abolished within the mutated element,
whereas protection of other elements was not affected.

View larger version (83K):
[in a new window]
Fig. 2.
Identification of in vitro protein-binding sites in the hamster TK promoter by DNase I
protection assays. The coding strand of the
319/+51 TK promoter
fragment was 5'-end-labeled and used in the absence (
) or presence
(+) of nuclear extract (Nucl. ext.) from exponentially
growing BHK cells. A, footprint analysis of wild-type
(wt) or mutated (m) promoter fragments containing
different mutations, as indicated; B, competition experiment
with Sp1 oligonucleotide. A 100-fold excess of an oligonucleotide
containing the mouse TK promoter Sp1 site was added prior to the
addition of the end-labeled wild-type promoter fragment. DNase
I-protected sequences are indicated by brackets.
99
and
57 accommodates three GC boxes, representing potential binding
sites for the Sp1 transcription factor family. Electrophoretic mobility
shift experiments were performed with nuclear extracts from
logarithmically growing BHK cells. Each of the GC-containing oligonucleotide probes produced three shifted complexes, which could be
supershifted with antibodies against Sp1 and Sp3 (Fig. 3, B-D). All three complexes
were competed by a 100-fold excess of an oligonucleotide probe
containing the previously demonstrated motif for Sp1 in the murine
promoter (8), but not by probes containing a cAMP-responsive
element-binding protein or YY1 recognition site (Fig. 3E).
The same result was verified in DNase I footprint experiments using the
murine Sp1 probe in competition with the end-labeled wild-type promoter
fragment (Fig. 2B). The fact that protein binding to GC
boxes of the hamster TK promoter is strongly inhibited by an
oligonucleotide carrying an Sp1/Sp3-binding motif present in another
promoter, together with the supershift induced by Sp1- and Sp3-specific
antibodies, provides compelling evidence for the conclusion that the
region between positions
99 and
57 is indeed protected by three
protein complexes of the Sp1 transcription factor family. Furthermore,
it was demonstrated that the transcription factor binding to the CCAAT
box is NF-Y, as antibodies against NF-YA and NF-YB, two of the three
subunits of NF-Y, shifted the protein complex formed on the CCAAT
oligonucleotide (Fig. 3A). An independent strong indication
for an involvement of NF-Y in hamster TK promoter activity was obtained
as follows. Promoter-luciferase reporter constructs were transfected
into BHK cells alone or together with an expression plasmid carrying
the information for a dominant-negative NF-YA subunit (20). This
mutated NF-YA interferes with the formation of a functional,
heterotrimeric DNA-binding complex. As shown in Fig.
4, the activity of the hamster TK
promoter was significantly reduced by cotransfection of the
dominant-negative NF-YA mutant, but not by cotransfection of wild-type
NF-YA.

View larger version (52K):
[in a new window]
Fig. 3.
Protein complexes interacting with binding
sites in the TK promoter. A-D, electrophoretic
mobility shift assays were performed by incubating nuclear extracts
from exponentially growing BHK cells with the indicated oligonucleotide
probes. E, whole cell extracts from growing BHK cells or
from those synchronized in G0 by serum starvation and
restimulated with serum for the indicated times were used. The
oligonucleotides used as DNA probes were as follows: mE2F,
E2F-binding element of the mouse TK promoter; h"E2F",
E2F-like binding element of the hamster TK promoter. Antibodies
(Ab) and competitors (Comp.; 100-fold molar
excess) were added as indicated. Specific complexes are marked with
arrows. CREB, cAMP-responsive element-binding
protein.

View larger version (33K):
[in a new window]
Fig. 4.
TK promoter activity is repressed by a
dominant-negative mutant of NF-YA. BHK cells growing on 3-cm Petri
dishes were transiently transfected with 1.2 µg of DNA from a mixture
made up of 1 µg of wild-type hamster TK promoter-luciferase construct
(pGL3haTK), the indicated amounts of expression vectors encoding
dominant-negative NF-YA (pNF-YA29; Ref. 20) or wild-type NF-YA
(pNF-YA13), 0.5 µg of pCMV
gal as an internal control for
transfection efficiency, and pcDNA3 empty plasmid to bring the
total amount of the DNA mixture to 3 µg. The relative activity of
luciferase to
-galactosidase is presented. The means ± S.D. of
two independent experiments are shown as -fold induction of the
activity obtained with the TK promoter-luciferase construct transfected
alone.
114)-Luc), had little influence on
promoter strength and no effect on growth-regulated expression
(~4-fold). More important, neither the down-regulation of the
promoter in quiescent cells nor the induction after serum addition was
affected by removal of the E2F-like sequence (Fig. 5B). This
indicates that neither a repressor element acting in G0 nor
an activator element acting in S phase was removed. Furthermore, the
additional removal of GC boxes 1 and 2 (pTK(
92)-Luc and
pTK(
73)-Luc) had only minor consequences for promoter strength and no
influence on promoter regulation (~4-fold). The 122-base pair region
between positions
73 and + 51, carrying a single GC box, the reversed
CCAAT motif, and the TATA box, therefore functions as a minimal
promoter that is still growth-regulated like the full-length promoter
(pTK(
319)-Luc). This indicates that one of the three binding
elements, or a combination of them, is essential for the observed
activity. When the most proximal Sp1-binding site was deleted, leaving
only the reversed CCAAT box and the TATA box (pTK(
65)-Luc), promoter
activity was dramatically reduced (~4% of wild-type expression).
Still, this construct exhibited growth-regulated expression of
luciferase similar to the transgenes carrying the extended promoters
(Fig. 5B).

View larger version (27K):
[in a new window]
Fig. 5.
Deletion analysis of the TK promoter.
Truncated forms of the TK promoter cloned in front of the luciferase
gene, as indicated in A, were stably integrated into the
genome of BHK cells. A, a schematic representation of
truncated TK promoter-luciferase (Luc) constructs is shown
on the left. The relative luciferase activities in growing cells
(log), normalized to 100 for the wild type, are shown on the
right. B, stable cell lines containing TK-luciferase
constructs, as indicated, were synchronized in G0 by serum
starvation, and the luciferase activity was measured after
restimulation with serum. The -fold induction by serum stimulation,
normalized for each individual promoter-luciferase construct to a value
of 1 for 0 h, is presented. The values in A and
B are the means of three independent experiments. S.D. was
included in A. C, shown are the data from
fluorescence-activated cell sorter analyses of synchronized BHK cells,
containing the wild-type promoter-luciferase construct stably
integrated, after release from serum deprivation.

View larger version (31K):
[in a new window]
Fig. 6.
Functional requirement of individual
cis-acting elements for transcription and
growth-regulated expression of stably integrated reporter genes.
A, a schematic representation of the wild-type
(wt) and mutated (m) promoter regions of the
hamster TK gene used for the production of TK-luciferase
(Luc) constructs is shown on the left. Site-specific
disruption of individual elements is indicated (×). The relative
luciferase activities in growing cells, normalized to 100 for the wild
type, are indicated on the right. The means ± S.D. of three
independent experiments are shown. B, stable BHK cells
containing the constructs indicated in A were synchronized
in G0 by serum deprivation for 72 h, and the
luciferase activity was measured following restimulation with serum.
The values are the means of three independent experiments and are
represented as -fold induction normalized for each individual construct
to 1 for the 0-h time point. C, the site-specific mutations
and their respective names are shown together with the corresponding
wild-type sequence.
319/+51
hamster TK promoter fragment (pGL3haTK) or the murine TK promoter
(pGL3mTK) were transiently transfected into SAOS-2 osteosarcoma cells
together with an expression vector for E2F-1. As expected,
overexpression of E2F-1 transactivated the murine promoter, which was
further stimulated by cotransfection of DP-1 or inhibited by pRb (Fig.
7, bars 5-10). In contrast, the activity of the hamster promoter remained unchanged when
cotransfected with E2F-1 alone or together with DP-1 (Fig. 7,
bars 1-3). These results strongly suggest that the hamster
TK promoter is regulated in an E2F-independent manner.

View larger version (21K):
[in a new window]
Fig. 7.
Effect of E2F on the transactivation of the
mouse and hamster TK promoters. SAOS-2 cells growing on 3-cm Petri
dishes were transiently transfected with 1.8 µg of DNA from a mixture
made up of 2 µg of either wild-type hamster (pGL3haTK) or wild-type
mouse (pGL3mTK) TK promoter construct, expression plasmids encoding
E2F-1 (0.5 µg; bars 2-4 and 7-9) and DP-1 (2 µg; bars 3 and 8) or Rb (3 µg (bars
4 and 9) and 1.5 µg (bars 5 and
10)), and 0.5 µg of pCMV
gal as an internal control for
transfection efficiency. pcDNA3 empty plasmid was added as required
to bring the total amount of DNA in the mixture to 6 µg. The relative
activity of luciferase to
-galactosidase is presented. The
means ± S.D. of three independent experiments are shown as -fold
induction of the activity obtained with the TK promoter reporter
plasmid transfected alone.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
73 and +51
(relative to the transcription initiation site) as a minimal promoter,
which conferred both efficient and serum-responsive expression of a
reporter gene (Fig. 5). Within this region, a single binding site for
Sp1, the CCAAT box, and the TATA box are present. Furthermore, it was
apparent from mutational analysis that all three elements contribute
significantly to the promoter strength and that the CCAAT box is
important for promoter regulation (Figs. 5 and 6). Electrophoretic
mobility shift assays identified NF-Y as the transcription factor that
binds to the CCAAT box (Fig. 3A). Evidence that this
transcription factor is functional at the hamster TK promoter was
obtained with the help of a dominant-negative mutant that inhibited
expression of a promoter-transgene construct (Fig. 4).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Diane Mathis for providing antibodies against NF-YA and NF-YB; R. Mantovani for the expression plasmids NF-YA29 and NF-YA13; and Hans Rotheneder, Egon Ogris, and Christian Seiser for discussions.
| |
FOOTNOTES |
|---|
* This work was supported by Fonds zur Förderung der Wissenschaftlichen Forschung Grant 12212-MOL.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) X99216.
Member of the Vienna Biocenter Ph.D. program.
§ To whom correspondence should be addressed. Tel.: 43-1-4277-61704; Fax: 43-1-4277-1705; E-mail: Wi@Mol.Univie.Ac.At.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: TK, thymidine kinase; BHK, baby hamster kidney.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Wintersberger, E., Rotheneder, H., Grabner, M., Beck, G., and Seiser, C. (1992) Adv. Enzyme Regul. 32, 241-254[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Wintersberger, E. (1997) Biochem. Soc. Trans. 25, 303-308[Medline] [Order article via Infotrieve] |
| 3. | Slansky, J. E., and Farnham, P. J. (1996) Bioessays 18, 55-62[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Seiser, C.,
Knöfler, M.,
Rudelstorfer, I.,
Haas, R.,
and Wintersberger, E.
(1989)
Nucleic Acids Res.
17,
185-195 |
| 5. |
Ogris, E.,
Rotheneder, H.,
Mudrak, I.,
Pichler, A.,
and Wintersberger, E.
(1993)
J. Virol.
67,
1765-1771 |
| 6. |
Dou, Q.-P.,
Zhao, S.,
Levin, A. H.,
Wang, J.,
Helin, K.,
and Pardee, A. B.
(1994)
J. Biol. Chem.
269,
1306-1313 |
| 7. |
Mudrak, I.,
Ogris, E.,
Rotheneder, H.,
and Wintersberger, E.
(1994)
Mol. Cell. Biol
14,
1886-1892 |
| 8. | Karlseder, J., Rotheneder, H., and Wintersberger, E. (1996) Mol. Cell. Biol. 16, 1659-1667[Abstract] |
| 9. |
Arcot, S. S.,
Flemington, E. K.,
and Deininger, P. L.
(1989)
J. Biol. Chem.
264,
2343-2349 |
| 10. |
Lewis, J. A.,
Shimizu, K.,
and Zipser, D.
(1983)
Mol. Cell. Biol.
3,
1815-1823 |
| 11. |
Lewis, J. A.
(1986)
Mol. Cell. Biol.
6,
1998-2010 |
| 12. |
Lewis, J. A.,
and Matkovich, D. A.
(1986)
Mol. Cell. Biol.
6,
2262-2266 |
| 13. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 14. | Aubin, C. C., Weinfeld, M., and Paterson, M. C. (1988) Somatic Cell Mol. Genet. 14, 155-167[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Baker, A., Saltik, M., Lehrmann, H., Killisch, I., Mautner, V., Lamm, G., Christofori, G., and Cotten, M. (1997) Gene Ther. 4, 773-782[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Dignam, J. D.,
Lebovitz, R. M.,
and Roeder, R. G.
(1983)
Nucleic Acids Res.
11,
1475-1489 |
| 17. | Barberis, A., Superti-Furga, G., and Busslinger, M. (1987) Cell 50, 347-359[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Li, L.-J.,
Naeve, G. S.,
and Lee, A. S.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3554-3558 |
| 19. | Anderson, M. M., Chen, J., Cole, C. N., and Conrad, S. E. (1996) J. Virol. 70, 6304-6313[Abstract] |
| 20. |
Mantovani, R.,
Li, X.-Y.,
Pessara, U.,
van Huisjduijnen, R. H.,
Benoist, C.,
and Mathis, D.
(1994)
J. Biol. Chem.
269,
20340-20346 |
| 21. | Helin, K. (1998) Curr. Opin. Genet. Dev. 8, 8-35 |
| 22. | Kim, E. C., Rawlings, S. L., Li, L.-J., Roy, B., and Lee, A. S. (1996) Cell Growth Differ. 7, 1741-1749[Abstract] |
| 23. | Maity, S. N., and de Crombrugghe, B. (1998) Trends Biochem. Sci. 23, 174-178[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Mantovani, R., Pessara, U., Tronche, F., Li, X.-Y., Knapp, A.-M., Pasquali, J.-L., Benoist, C., and Mathis, D. (1992) EMBO J. 11, 3315-3322[Medline] [Order article via Infotrieve] |
| 25. |
Filatov, D.,
and Thelander, L.
(1995)
J. Biol. Chem.
270,
25239-25243 |
| 26. |
Hsiao, K. M.,
McMahon, R.,
and Farnham, P. J.
(1994)
Genes Dev.
8,
1526-1537 |
| 27. | Katula, K. S., Wright, K. L., Paul, H., Surman, D. R., Nuckolls, F. J., Smith, J. W., Ting, J. P.-J., Yates, J., and Cogswell, J. P. (1997) Cell Growth Differ. 8, 811-820[Abstract] |
| 28. | Zwicker, J., Lubicello, F. C., Wolfraim, L. A., Gross, C., Truss, M., Engeland, K., and Müller, R. (1995) EMBO J. 14, 4514-4522[Medline] [Order article via Infotrieve] |
| 29. | Good, L., Chen, J., and Chen, K. Y. (1995) J. Cell. Physiol. 163, 636-644[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Chang, Z.-F.,
and Liu, C.-J.
(1994)
J. Biol. Chem.
269,
17893-17898 |
| 31. | Kim, E. C., Lau, J. S., Rawlings, S., and Lee, A. S. (1997) Cell Growth Differ. 8, 1329-1338[Abstract] |
| 32. |
Tommasi, S.,
and Pfeifer, G. P.
(1997)
J. Biol. Chem.
272,
30483-30490 |
| 33. |
Roder, K.,
Wolf, S. S.,
Beck, K.-F.,
and Schweizer, M.
(1997)
J. Biol. Chem.
272,
21616-21624 |
| 34. |
Wright, K. L.,
Moore, T. L.,
Vilen, B. J.,
Brown, A. M.,
and Ting, J. P.-Y.
(1995)
J. Biol. Chem.
270,
20978-20986 |
| 35. | Wright, K. L., Vile, B. J., Itoh-Lindstrom, Y., Moore, T. L., Li, G., Criscitiello, M., Cogswell, P., Clarke, J. B., and Ting, J. P.-Y. (1994) EMBO J. 13, 4042-4053[Medline] [Order article via Infotrieve] |
| 36. | Linhoff, M. W., Wright, K. L., and Ting, J. P.-Y. (1997) Mol. Cell. Biol. 17, 4589-4596[Abstract] |
| 37. |
Trouche, D.,
and Kouzarides, T.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1439-1442 |
| 38. | Luo, R. X., Postigo, A. A., and Dean, D. C. (1998) Cell 92, 463-473[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., and Kouzarides, T. (1998) Nature 391, 597-601[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., LeVillain, J. P., Troalen, F., Trouche, D., and Harei-Bellan, A. (1998) Nature 391, 601-605[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Currie, R. A.
(1998)
J. Biol. Chem.
273,
1430-1434 |
| 42. | Li, Q., Herrler, M., Landsberger, N., Kaludov, N., Ogryzko, V. V., Nakatani, Y., and Wolffe, A. P. (1998) EMBO J. 17, 6300-6315[CrossRef][Medline] [Order article via Infotrieve] |
| 43. |
Doetzelhofer, A.,
Rotheneder, H.,
Koranda, M.,
Lagger, G.,
Kurtev, L.,
Brosch, G.,
Wintersberger, E.,
and Seiser, C.
(1999)
Mol. Cell. Biol.
19,
5504-5511 |
This article has been cited by other articles:
![]() |
M. Kotecha, J. Kluza, G. Wells, C. C. O'Hare, C. Forni, R. Mantovani, P. W. Howard, P. Morris, D. E. Thurston, J. A. Hartley, et al. Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78 Mol. Cancer Ther., May 1, 2008; 7(5): 1319 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kanai, D. Wei, Q. Li, Z. Jia, J. Ajani, X. Le, J. Yao, and K. Xie Loss of kruppel-like factor 4 expression contributes to sp1 overexpression and human gastric cancer development and progression. Clin. Cancer Res., November 1, 2006; 12(21): 6395 - 6402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Minuzzo, M. Ceribelli, M. Pitarque-Marti, S. Borrelli, E. Erba, A. diSilvio, M. D'Incalci, and R. Mantovani Selective Effects of the Anticancer Drug Yondelis (ET-743) on Cell-Cycle Promoters Mol. Pharmacol., November 1, 2005; 68(5): 1496 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Leyton, J. R. Latigo, M. Perumal, H. Dhaliwal, Q. He, and E. O. Aboagye Early Detection of Tumor Response to Chemotherapy by 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography: The Effect of Cisplatin on a Fibrosarcoma Tumor Model In vivo Cancer Res., May 15, 2005; 65(10): 4202 - 4210. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, D. Wei, S. Huang, Z. Peng, X. Le, T. T. Wu, J. Yao, J. Ajani, and K. Xie Transcription Factor Sp1 Expression Is a Significant Predictor of Survival in Human Gastric Cancer Clin. Cancer Res., December 15, 2003; 9(17): 6371 - 6380. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schuettengruber, E. Simboeck, H. Khier, and C. Seiser Autoregulation of Mouse Histone Deacetylase 1 Expression Mol. Cell. Biol., October 1, 2003; 23(19): 6993 - 7004. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Barthel, M. C. Cleij, D. R. Collingridge, O. C. Hutchinson, S. Osman, Q. He, S. K. Luthra, F. Brady, P. M. Price, and E. O. Aboagye 3'-Deoxy-3'-[18F]Fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative Therapy in Vivo with Positron Emission Tomography Cancer Res., July 1, 2003; 63(13): 3791 - 3798. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schuettengruber, A. Doetzlhofer, K. Kroboth, E. Wintersberger, and C. Seiser Alternate Activation of Two Divergently Transcribed Mouse Genes from a Bidirectional Promoter Is Linked to Changes in Histone Modification J. Biol. Chem., January 10, 2003; 278(3): 1784 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zhou and C.-M. Chiang Sp1 and AP2 regulate but do not constitute TATA-less human TAFII55 core promoter activity Nucleic Acids Res., October 1, 2002; 30(19): 4145 - 4157. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Haugwitz, M. Wasner, M. Wiedmann, |